Filters

Leonid N Maslov, Sergey V Popov, Natalia V Naryzhnaya, Alexandr V Mukhomedzyanov, Boris K Kurbatov, Ivan A Derkachev, Alla A Boshchenko, Igor Khaliulin, N Rajendra Prasad, Nirmal Singh, Alexei Degterev, Evgenia A Tomilova, Ekaterina V Sapozhenkova

Apoptosis : an international journal on programmed cell death 2022;27(9-10):697-719

Full Text

Abstract

Reactive oxygen species regulate Smac mimetic/TNFα-induced necroptotic signaling and cell death.

B Schenk, S Fulda

Oncogene 2016;34(47):5796-806

Full Text

Abstract

Molecular features of the cytotoxicity of an NHE inhibitor: Evidence of mitochondrial alterations, ROS overproduction and DNA damage.

Francesca Aredia, Sebastian Czaplinski, Simone Fulda, A Ivana Scovassi

BMC cancer 2017;16(1):851

Free Full Text

Abstract

Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis.

Kwang Seok Ahn, Gautam Sethi, Koyamangalath Krishnan, Bharat B Aggarwal

The Journal of biological chemistry 2007;282(1):809-20

Free Full Text

Abstract

Modulation of TRAIL signaling complex.

Jin H Song, Chunhai Hao, Urosh Vilimanovich, Norman M Kneteman

Vitamins and hormones 2004;67():81-99

Full Text

Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.

Sabine Hannes, Behnaz Ahangarian Abhari, Simone Fulda

Cancer letters 2017;380(1):31-8

Full Text

Abstract

Results: 1 – 13 / 13

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Receptor-Interacting Protein Serine-Threonine Kinases""[mesh_terms]

Protein phosphorylation and kinases: Potential therapeutic targets in necroptosis.

Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic Potential.

Molecular Insights into the Mechanism of Necroptosis: The Necrosome As a Potential Therapeutic Target.

Role of Necroptosis, a Regulated Cell Death, in Seizure and Epilepsy.

Role of RIPK3‑CaMKII‑mPTP signaling pathway‑mediated necroptosis in cardiovascular diseases (Review).

Silymarin induces a multi-targeted cell death process in the human colon cancer cell line HT-29.

A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants.

The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury.

Reactive oxygen species regulate Smac mimetic/TNFα-induced necroptotic signaling and cell death.

Molecular features of the cytotoxicity of an NHE inhibitor: Evidence of mitochondrial alterations, ROS overproduction and DNA damage.

Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis.

Modulation of TRAIL signaling complex.

Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.

Results for

""Receptor-Interacting Protein Serine-Threonine Kinases""[mesh_terms]